Atomoxetine treatment of adults with ADHD [attention-deficit hyperactivity disorder] and comorbid alcohol abuse: a randomized, placebo-controlled trial
Phase of Trial: Phase IV
Latest Information Update: 20 May 2015
At a glance
- Drugs Atomoxetine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Sponsors Eli Lilly
- 01 Jul 2008 Results published in the journal, Drug and Alcohol Dependence.
- 21 Jan 2006 New trial record.